Literature DB >> 29949701

EFFECT OF 3-HYDROXYPYRIDINE AND SUCCINIC ACID DERIVATIVES ON BACTERIAL GROWTH IN DISCONTINUOUS CULTURES.

I A Volchegorskii, E V Pravdin, A V Pospelova, T V Uzlova.   

Abstract

We have studied the effect of domestic derivatives of 3-hydroxypyridine and succinic acid (emoxipine, reamberin, and mexidol) on proliferation of E. coli, S. aureus and E. faecalis in discontinuous cultures (DCs) over a period of 1 or 24 h. It is established that the drugs studied exhibit a biphase effect on the number of bacterial colony-forming units (CFUs) in DCs of E. coli and E.faecalis. This effect is manifested by the initial 1.3 - 3.5-fold decrease in the number of CFUs (after 1-h incubation with drugs) with subsequent return to the control level or 1.8 - 8.8-fold increase over the control level (after 24-h incubation with drugs). In DCs of S. aureus that were incubated with the drugs, we observed 1.1 - 1.95-fold increase in CFU number after I-h incubation and 1.8 - 2.4-fold increase after 24-h incubation. On the whole, the results of our studies demonstrated a positive effect of 3-hydroxypyridine and succinic acid derivatives on bacterial growth in DC. These drugs stimulated increase in CFU number in DCs of test bacterial strains even at concentrations as low as 10⁻⁹ -10⁻⁶. The well-known efficiency of 3-hydroxypyridine and succinic acid derivatives in treatment of infectious pathology appears independent of their direct effect on bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29949701

Source DB:  PubMed          Journal:  Eksp Klin Farmakol        ISSN: 0869-2092


  1 in total

1.  Chemical Profile and Antimicrobial Activity of the Fungus-Growing Termite Strain Macrotermes Bellicosus Used in Traditional Medicine in the Republic of Benin.

Authors:  Dima Hammoud Mahdi; Jane Hubert; Jean-Hugues Renault; Agathe Martinez; Andreas Schubert; Kathrin Monika Engel; Blaise Koudogbo; Zacharie Vissiennon; Virgile Ahyi; Karen Nieber; Cica Vissiennon
Journal:  Molecules       Date:  2020-10-29       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.